Subscribe to our newsletter

Multiple Sclerosis Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.
3100 +
STUDY VISITS
1476 +
PATIENTS
40 +
NEUROLOGISTS
MS Map

Participating Sites

CorEvitas has clinical sites across the U.S. and we are always interested in expanding the registry for qualified sites.
LEARN MORE

Outcome measures in the CorEvitas MS Registry.

Among the variables we collect, some of the key outcome measures to inform your research include:

Clinician Reported Outcomes

  • Relapse rate (12 and 24 months)
  • Timed 25-foot walk (T25-FW)
  • 9-Hole peg test (9-HPT)
  • Symbol digit modalities test (SDMT)
  • Clinical global impression scale (CGI)

Patient Reported Outcomes

  • MS Disability Score: Patient Determined Disease Steps (PDDS)
  • Depression Outcome: Patient Health Questionnaire-2 (PHQ-2)
  • Multiple Sclerosis Impact Scale (MSIS-29)
  • Work Productivity and Activity Impairment (WPAI)
  • Fatigue (shortened, modified Fatigue Impact Scale)
  • Patient Global Impression of Change (PGIC)
  • Pain Numerical Rating Scale

Our Publications

MANUSCRIPTS AND ABSTRACTS

Other Registries

Question about a registry?

Contact Us